Single-Fraction Very Accelerated Partial Breast Irradiation (sfVAPBI)

To investigate clinical outcomes, late side effects, and cosmetic results of a single-fraction very accelerated partial breast irradiation as postoperative local treatment for the treatment of early stage breast cancer.

Trial Details

NCT ID
NCT07067437
Phase
NA
Sponsor
National Institute of Oncology, Hungary
Status
RECRUITING
Cancer Type
Breast Cancer
Interventions
  • single-fraction very accelerated partial breast irradiation
Locations (sample)
  • Lyon, France|45.74906,4.84789
  • Nancy, France|48.68439,6.18496
  • Nice, France|43.70313,7.26608
  • Bremerhaven, Germany|53.55357,8.57553
  • Erlangen, Germany|49.59099,11.00783

Key Eligibility Criteria

  • Stage 0 \& I \& II (\< 3 cm) breast carcinoma
  • Lesions of \< 3 cm diameter
  • Invasive carcinoma of any subtype and grade or ductal carcinoma in situ (DCIS)
  • Nodal status: node-negative (pN0) or micro-metastatic (pN1mi) (patients with pN1mi status can be treated, but due to the limited clinical evidence,…

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Breast Cancer Trials on Trialify →